We are live on
!
Find out more
BP
BCK Partners Portfolio holdings
AUM
$207M
1-Year Est. Return
18%
This Fund
S&P 500
This Quarter
Est. Return
+6.03%
1 Year Est. Return
+18%
3 Year Est. Return
+44.58%
5 Year Est. Return
+37.67%
10 Year Est. Return
–
AUM
$210M
AUM Growth
+$16.1M
(+8.3%)
Cap. Flow
+$4.46M
Cap. Flow
% of AUM
2.13%
Top 10 Holdings %
Top 10 Hldgs %
95.18%
Holding
30
New
–
Increased
13
Reduced
11
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
|
+$2.87M |
| 2 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$2.09M |
| 3 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$283K |
| 4 |
Vanguard Morningstar Small-Cap ETF
VB
|
+$261K |
| 5 |
Schwab International Equity ETF
SCHF
|
+$57.1K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$371K |
| 2 |
Corning
GLW
|
+$366K |
| 3 |
Thermo Fisher Scientific
TMO
|
+$236K |
| 4 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$66.2K |
| 5 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$28.4K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.27% |
| 2 | Healthcare | 0.92% |
| 3 | Financials | 0.61% |
| 4 | Consumer Discretionary | 0.23% |
| 5 | Industrials | 0.19% |
Similar funds
MPCG
SG
SNBOSD
BWM
CC
HCA
KIC
JWM
BCK Partners's Q3 2024 Portfolio in Review
As of Q3 2024, BCK Partners held 30 positions worth $210M, up 8.3% from $193M the previous quarter. Its ten largest holdings account for 95% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 3.3%. BCK Partners opened no new positions and exited 1, leaving the 30-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 2.3% of assets, down from 2.4% a quarter earlier, followed by Healthcare and Financials.
- BCK Partners added most to iShares 5-10 Year Investment Grade Corporate Bond ETF in Q3 2024, an estimated $2.87M increase.
- BCK Partners's biggest Q3 2024 reduction was Berkshire Hathaway Class B, cutting an estimated $371K.
- BCK Partners fully exited Thermo Fisher Scientific in Q3 2024, selling an estimated $236K.
- BCK Partners's ten largest holdings make up 95% of its $210M portfolio in Q3 2024.
- BCK Partners opened 0 new positions and closed 1 in Q3 2024.
- BCK Partners's portfolio value rose 8.3% quarter-over-quarter to $210M.
Based on BCK Partners's 13F filing for Q3 2024, filed 25 Oct 2024.